LTP ltr pharma limited

3.45%

30.0¢

Do you know the reasoning of why TGA approval after FDA...

First 115 Last

Share
Profile

Follow
Mariner985

62 Posts.

44

27/03/25

08:21

Post #: 78433328
Share

Originally posted by AdamThompson: ↑

The commentators on this site have not paid attention along the way. The company is getting their product approved by the FDA and after its approved they will get it approved by the TGA. There is no misleading of shareholders. The only comment on misleading is that the CEO wants to ensure he has everything done before we get an announcement. He is s an honest and careful thinker. Plus he has the best pharma advisors in his corner. Wait until he gets an offer to sell the product with a $1b royalty advance !! I suspect we will see such a thing in Q3.

This company is on its way to being a $4-5b company. It’s partnered with experienced firms and is on track to be a winner.

The only new news that is off track is a slight pivot to access the US early access system like we have in Australia using Spontan but renaming it Roxus. It’s an amazingly clever move and will produce revenue short term and will expose the product to the US market.

A1 action and the outcome will increase value immediately. Well done Lee and the company team.

The only reason we have a falling share price is because some unfortunate shareholder had to close their position. That was followed with others getting scared and frighten. Fear feeds fear and share prices go down.

None of the top 20 shareholders have gone anywhere and I am one of them.

Hopefully everyone will understand what I am saying when Lee presents tomorrow.

Try to stop saying dumb things on this site. It’s a waste of time and a reminder nobody has misled you.

Expand

Do you know the reasoning of why TGA approval after FDA approval?

Do you mind sharing the latest top 20 please.

LTP Price at posting: 43.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

First 115 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 30.0¢		Change 0.010(3.45%)		Mkt cap ! $33.58M

Open	High	Low	Value	Volume
29.0¢	30.0¢	28.5¢	$105.7K	362.0K

Buyers (Bids)

No.	Vol.	Price($)
1	17000	29.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.0¢	407	1

View Market Depth

No.	Vol.	Price($)
1	17000	0.290
1	24000	0.285
2	230000	0.280
5	137909	0.275
10	192157	0.270

Price($)	Vol.	No.
0.305	9760	1
0.310	3286	1
0.315	9460	1
0.320	4762	2
0.325	79383	2

Last trade - 16.10pm 27/06/2025 (20 minute delay)

LTP (ASX) Chart

Do you know the reasoning of why TGA approval after FDA...

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Do you know the reasoning of why TGA approval after FDA...

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News